#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast angiosarcoma Angelman's syndrome Neuroblastoma Oesophageal squamous cell carcinoma stage III Anti-myelin-associated glycoprotein antibodies positive Phaeochromocytoma Neurodegenerative disorder Alagille syndrome Inflammatory myofibroblastic tumour Chronic graft versus host disease in skin Microvillous inclusion disease Dermatitis Astrocytoma malignant Leukaemia Osteogenesis imperfecta More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Basic Information Hereditary hypophosphataemic rickets – Treatment Primary immunodeficiency syndrome – Treatment Chordoma – Diagnostics Soft tissue sarcoma – Treatment Mantle cell lymphoma refractory – Basic Information Progressive multifocal leukoencephalopathy Familial haemophagocytic lymphohistiocytosis – Trials in Disease Von Willebrand’s disease – Basic Information KBG syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abbv-668 Lucerastat Adalimumab Trametinib LY3841136 SODIUM Azd0305 TIFCEMALIMAB Tetrahydrouridine Lysine Aspirin Relacorilant ZINC CHLORIDE Sunvozertinib SAR443820 Quinidine Sulfate Ozanimod Hydrochloride Nvl-655 Revumenib Zamtocabtagene Autoleucel Tolu Balsam Bendamustine Hydrochloride More therapies…

    Learn about Your Condition

    Neuropathic arthropathy Gastrointestinal melanoma Endometrial cancer stage III Pancreatic failure Metabolic syndrome Pleomorphic leiomyosarcoma Migraine without aura Burning mouth syndrome Laparotomy Stomatitis Onychomycosis Neonatal respiratory failure Migraine Non-small cell lung cancer Epstein-Barr virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neuroblastoma

  • Study Comparing [18F]meta-fluorobenzylguanidine PET-CT and Iodine (123I) Iobenguane Scans for Detecting Neuroblastoma in Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Iodine (123I) Iobenguane
    • [18F]Meta-Fluorobenzylguanidine
    The Netherlands

  • Study of ABTL0812, Irinotecan, and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    • Neoplasm
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    • Irinotecan
    • Temozolomide
    Spain

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Melphalan
    • Thiotepa
    Austria Belgium Czechia Denmark Finland France +11

  • Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    • Inflammatory myofibroblastic tumour
    • Neuroblastoma
    Investigated Drugs:
    • Temsirolimus
    • Crizotinib
    Denmark Finland France Germany Italy The Netherlands +3

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    • Gd2Il18Cart
    • Anakinra
    Germany

  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Central nervous system neuroblastoma
    • Neuroblastoma
    Investigated Drugs:
    • Human Albumin Solution
    • Water For Injection
    • Dinutuximab Beta
    Austria France Germany Italy The Netherlands Poland +1
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!